Holen Sie sich die Stockscreener-App
83.38
0.58%
0.48
Vorhandelsmarkt:
83.67
0.29
+0.35%
Schlusskurs vom Vortag:
$82.90
Offen:
$82.72
24-Stunden-Volumen:
1.52M
Relative Volume:
1.43
Marktkapitalisierung:
$14.46B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
38.60
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+9.44%
1M Leistung:
+16.71%
6M Leistung:
+17.75%
1J Leistung:
+17.75%
1-Tages-Spanne:
$82.53
$83.97
1-Wochen-Bereich:
$75.25
$83.97
52-Wochen-Spanne:
$60.70
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
83.38 | 14.38B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
568.48 | 199.09B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
190.96 | 55.24B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
76.25 | 37.63B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.52 | 36.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
273.99 | 19.50B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Stock Surges 13%, With A 8-Day Winning Spree - Trefis
Solventum (SOLV): Assessing Valuation After $1 Billion Share Buyback Announcement - Yahoo Finance
Solventum Seeks to Chart Its Own Path, Improve Operations, and Raise Profitability - Morningstar
Model ML raises again, gene-editing gains backers and Solventum's wound care buy - Axios
Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - Yahoo Finance
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock - Fierce Biotech
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Stocks Flashing Renewed Technical Strength: Solventum - Investor's Business Daily
Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha
Solventum sets $1 billion share repurchase program - MSN
Quick ratio of Solventum Corporation – HAM:KB7 - TradingView
Solventum to buy private wound care firm Acera for up to $850M - MSN
Solventum To Buy Acera Surgical In $850 Million Deal To Expand Advanced Wound Care Portfolio - Pulse 2.0
Solventum stock rating reiterated by UBS, Acera deal fills wound care gap - Investing.com South Africa
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Yahoo Finance
Solventum Corporation Reports Strong Q3 2025 Results - MSN
Solventum Stock Gets Relative Strength Rating Lift - Investor's Business Daily
A Look at Solventum’s Valuation Following $1 Billion Share Buyback Authorization - simplywall.st
Acera Surgical, born from WashU research, to be acquired for up to $850M - The Business Journals
Agree To Buy Solventum At $70, Earn 6.6% Annualized Using Options - Nasdaq
Solventum inks $725M Acera takeover - MedTech Dive
Solventum Trying To Close In On Key Technical Measure - MSN
Solventum stock rating reiterated by UBS, Acera deal fills wound care gap By Investing.com - Investing.com Nigeria
Solventum agrees to buy regenerative wound care maker Acera Surgical for $725M+ - The Business Journals
How institutional buying supports Solventum Corporation stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges - TipRanks
Solventum to acquire Acera Surgical - Medical Buyer
How Solventum Corporation stock behaves in tightening cyclesBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential - TipRanks
Solventum announces $1 billion share repurchase program By Investing.com - Investing.com Nigeria
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Solventum stock rises on $1 billion share buyback, Acera acquisition By Investing.com - Investing.com Nigeria
Solventum stock rises on $1 billion share buyback, Acera acquisition - Investing.com
Solventum to Acquire Acera Surgical for $850M - Medical Device and Diagnostic industry
Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares - MassDevice
Solventum Corporation entered into a definitive agreement to acquire Acera Surgical, Inc. for $850 million. - MarketScreener
Solventum agrees to acquire Acera for up to $850M - BioWorld MedTech
Solventum to Buy Soft Tissue Repair Company Acera Surgical for up to $850M - Medical Product Outsourcing
Solventum to Buy Acera Surgical; Approves $1 Billion Share Repurchase Program - MarketScreener
Why Solventum Corporation Shares Are Climbing - TipRanks
Solventum to acquire Acera Surgical for $725 million - Investing.com
Solventum Corp (1SOLV.MI) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Solventum To Acquire Privately-held Acera Surgical For Up To $850 Mln - Nasdaq
Solventum to buy private wound care firm Acera (SOLV:NYSE) - Seeking Alpha
Solventum announces agreement to acquire Acera Surgical - MarketScreener
Solventum announces $1 billion share repurchase program - MarketScreener
Solventum to buy Acera Surgical for up to $850 million - MarketScreener
BRIEF-Solventum Announces Agreement To Acquire Acera Surgical - Devdiscourse
Solventum (NYSE: SOLV) to Buy Acera Surgical for $725M Cash Plus $125M Contingent - Stock Titan
Why Solventum Corporation (KB7) stock fits value portfoliosWeekly Trend Summary & Smart Money Movement Alerts - newser.com
Why Solventum Corporation (KB7) stock trades below fair valueTreasury Yields & Real-Time Volume Triggers - newser.com
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):